Astrocytic gap junction inhibition by carbenoxolone enhances the protective effects of ischemic preconditioning following cerebral ischemia

BACKGROUND: Stroke is the second leading cause of death worldwide and the most common cause of adult-acquired disability in many nations. Thus, attenuating the damage after ischemic injury and improving patient prognosis are of great importance. We have indicated that ischemic preconditioning (IP) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Di, Feng, Liangshu, Cheng, Yingying, Xin, Meiying, You, Jiulin, Yin, Xiang, Hao, Yulei, Cui, Li, Feng, Jiachun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034345/
https://www.ncbi.nlm.nih.gov/pubmed/29976213
http://dx.doi.org/10.1186/s12974-018-1230-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034345/
https://www.ncbi.nlm.nih.gov/pubmed/29976213
http://dx.doi.org/10.1186/s12974-018-1230-5

Ejemplares similares